期刊文献+

热化疗逆转人肝癌细胞系BEL-7402/ADM多药耐药性的实验研究 被引量:1

Effects of thermochemotherapy on drug resistance of multidrug-resistance human hepatocellular cell line BEL-7402/ADM
暂未订购
导出
摘要 目的 研究热化疗对多药耐药人肝癌细胞系BEL- 74 0 2 /ADM耐药性的影响并探讨相关的机制。方法 通过MTT法测定热化疗对多药耐药人肝癌细胞系BEL -74 0 2 /ADM耐药性影响;利用流式细胞仪检测多药耐药相关基因(MDR)的表达产物P糖蛋白(P- gp)、多药耐药相关蛋白(MRR)、谷胱甘肽转移酶(GSH/GST)的表达。结果 热化疗使多药耐药人肝癌细胞系BEL- 74 0 2 /ADM耐药性降低;P -gp、MRP和GSH/GST的表达均有所下降。结论 热化疗具有逆转多药耐药人肝癌细胞系BEL -74 0 2 /ADM耐药性的作用,可能与多药耐药相关基因表达水平下调有关。 Objective AIM Make a research on the effects of thermochemotherapy on drug resistance of multidrug resistance human hepatocellular cell line BEL-7402/ADM and inquire it's related regulation mechanism. Methods Investigate the effect of thermochemotherapy on the drug resistance of human hepatocellular cell line BEL-7402ADM by MTT assay; the P-gp, MRP and GSH-GST expression level were analyzed by flow cytometry. Results The drug resistance of mulidrug resistance human hepatocellular cell line BEL-7402/ADM after thermochemotherapy decreased; the expression of P-gp?MRP and GSH/GST also decreased. Conclusion thermochemotherapy had the reversal function on the drug resistance of multidrug resistance human hepatocellular cell line BEL-7402/ADM, which may be obtained by the decrease of multidrug resistance genes expression level.
出处 《中国实验诊断学》 2005年第2期189-191,共3页 Chinese Journal of Laboratory Diagnosis
关键词 肝癌 细胞系 放射治疗 药物耐受性 Hepatocellular carcinoma Cell line hyperthermia Drug resistance
  • 相关文献

参考文献5

  • 1张洪新,郭卫平,王执民,王义清,刘燕,高巍,李文献,倪代慧,梁志会,曹伟,关彦.阿霉素化疗与热化疗对人肝癌细胞耐药模型作用的比较[J].第四军医大学学报,2000,21(8):964-967. 被引量:5
  • 2al-Awqati Q. Regulation ofion channel by ABC transporters that secrete ATP[J]. Science, 1995,269(5225) :805.
  • 3Loe DW, Deeley RG, Cole SP. Biology of the multidrug resistance-associated protein, MRP[J]. E urJ Cancer, 1996,32A(6):954.
  • 4Brug D, Filippov DV, Hermanns R, et al. Peptidomimetic glutathione analogues as novel gammaGT stable GST inhibitors [J]. Bioorg Med Chem, 2002,10(1): 195.
  • 5Mistry P, Stewart AJ, Dangerfield W, et al. In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase Ⅰ and Ⅱ [J]. Anticancer Drugs, 2002,13(1):15.

二级参考文献4

共引文献4

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部